MorphoSys Successfully Concludes Therapeutic Antibody Project
August 08, 2005 02:15 ET | MorphoSys AG
MARTINSRIED, Germany, Aug. 8, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) announced today the successful conclusion of a first therapeutic antibody program with...
MorphoSys Reports Six Months 2005 Results
July 28, 2005 01:41 ET | MorphoSys AG
MARTINSRIED, Germany, July 28, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) today reported financial results according to IFRS for its first six months ended...
MorphoSys Strengthens Pre-clinical Development and Finance Departments in New Management Positions
July 18, 2005 01:31 ET | MorphoSys AG
MARTINSRIED, Germany, July 18, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment, TecDAX) announced today that it has strengthened its management in two...
MorphoSys Receives Award for Good Corporate Governance
July 13, 2005 06:05 ET | MorphoSys AG
MARTINSRIED, Germany, July 13, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) announced today that the Company achieved first place in the TecDAX segment of the...
MorphoSys Grants ImmunoGen Access to HuCAL GOLD
June 01, 2005 01:36 ET | MorphoSys AG
MARTINSRIED, Germany, June 1, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt Stock Exchange:MOR) (Prime Standard Segment, TecDAX) announced today that the US biotechnology company, ImmunoGen Inc., has...
MorphoSys Reports First Quarter 2005 Results
April 28, 2005 01:40 ET | MorphoSys AG
MARTINSRIED, Germany, April 28, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) today reported financial results according to IFRS for its first quarter ended March...
MorphoSys Provides Update on MOR102 Program in Psoriasis
April 28, 2005 01:37 ET | MorphoSys AG
MARTINSRIED, Germany, April 28, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (MOR; Prime Standard Segment, TecDAX) today provided an update on its MOR102 antibody program for chronic inflammatory...
Boehringer Ingelheim and MorphoSys Enlarge Collaboration
March 18, 2005 01:36 ET | MorphoSys AG
MARTINSRIED, Germany, March 18, 2005 (PRIMEZONE) -- Boehringer Ingelheim and MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) announced today an expansion of their existing cooperation...